<DOC>
	<DOCNO>NCT01289795</DOCNO>
	<brief_summary>The purpose study determine whether level circulate endothelial progenitor cell ( cEPC ) increase acute phase ischemic stroke .</brief_summary>
	<brief_title>Endothelial Function Progenitor Cells Acute Ischemic Stroke</brief_title>
	<detailed_description>Endothelial dysfunction key component atherosclerosis contributes development cardio- cerebrovascular disease . However , endothelial dysfunction ( ED ) establish risk factor ischemic stroke . As novelty propose trial investigate follow variety indirect marker endothelial function acute ischemic stroke : circulate endothelial progenitor cell ( EPC ) , endothelial microparticles ( EMP ) , ENDOPAT ( RH- PAT ratio ) two regard : 1. time ischemic event ( &lt; 48h , Days 4-5 , day 7 discharge ) 2. etiological stroke subtypes It known whether parameter change acute cerebral ischemia could possibly serve specific target treatment .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Patients first ever ischemic stroke TIA , transient symptom infarction ( TSI ) Age &gt; = 18 year old within 24 hour onset Written informed consent participate No evidence dysphagia Malignant hematopoietic disease ( e.g . leukemia ) , severe systemic infection , severe immunological disease , renal hepatic failure Pancreatitis , cholecystolithiasis , intestinal malabsorption Lactose intolerance Increased risk aspiration Pregnancy Life expectancy le 12 month Inability give write informed consent Psychosis Alcohol dependency Abuse illegal drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Cerebral Infarction</keyword>
	<keyword>Cerebrovascular Disorders</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Central Nervous System Diseases</keyword>
</DOC>